Evolent Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Evolent Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • Evolent Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $32M, a 54.8% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $32M -$38.8M -54.8% Dec 31, 2023 10-K 2024-02-23
Q4 2022 $70.8M -$30.6M -30.1% Dec 31, 2022 10-K 2024-02-23
Q4 2021 $101M +$11.6M +13% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $89.7M +$38.9M +76.6% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $50.8M +$13.8M +37.2% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $37M -$16.2M -30.4% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $53.2M +$26.8M +102% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $26.4M +$6.4M +32.1% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $20M +$13.1M +189% Dec 31, 2015 10-K 2017-03-03
Q4 2014 $6.92M Dec 31, 2014 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.